Literature DB >> 1721285

FK 506 modulates D-galactosamine-induced hepatitis in rats.

H Farghali1, A Gasbarrini, A B Borle, M A Nalesnik, A Francavilla, S Fagiuoli, T E Starzl, D H Van Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721285      PMCID： PMC2967299     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  12 in total

1.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse.

Authors:  S Yoshimura; N Kamada
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Toxicology of FK-506 in the Lewis rat.

Authors:  M A Nalesnik; S Todo; N Murase; S Gryzan; P H Lee; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

Authors:  D Kahn; H S Lai; H Romovacek; L Makowka; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletion.

Authors:  M De Brabander; H Van Belle; F Aerts; R Van De Veire; G Geuens
Journal:  Int J Immunopharmacol       Date:  1979

6.  Immunopotentiators and the protection they give against carbon tetrachloride hepatotoxicity.

Authors:  T Yoshikawa; Y Furukawa; Y Wakamatsu; M Kondo
Journal:  Experientia       Date:  1982-04-15

7.  Targeted protection of hepatocytes from galactosamine toxicity in vivo.

Authors:  V Keegan-Rogers; G Y Wu
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.

Authors:  M F Sakr; G M Zetti; T I Hassanein; H Farghali; M A Nalesnik; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

9.  Muramyl dipeptide and carbon tetrachloride hepatotoxicity in rats: involvement of plasma membrane and calcium homeostasis in protective effect.

Authors:  H Farghali; E Buchar; Z Machková; L Kameníková; K Masek
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-08

10.  The protection from hepatotoxicity of some compounds by the synthetic immunomodulator muramyl dipeptide (MDP) in rat hepatocytes and in vivo.

Authors:  H Farghali; Z Machková; L Kameníková; I Jankü; K Masek
Journal:  Methods Find Exp Clin Pharmacol       Date:  1984-08
View more
  1 in total

Review 1.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.